Nitromed, Inc

Premium Company Profile

Product Code DAT19544
Publication Date December 2007
Publisher Datamonitor
Product Type Report
Pages 49
ISBN Number not applicable
Change currency
PDF £170.00 €205 $269 BUY >
PRINT £200 €241 $316 BUY >
Order by fax
Ask a question about this product > Receive product alerts > Call now +44 20 7060 7474

Nitromed, Inc

Premium Company Profile

Introduction

NitroMed is focused on the development and commercialization of products for the treatment of diseases in the area of cardiology. The company applies Nitric Oxide (NO) technology to produce NO-based compounds. The company has only one marketed product, BiDil for the treatment of heart failure in African-American.

Scope

  • Contains corporate strategy, value chain presence and SWOT Analysis
  • Provides detailed business description, segment analysis, 5-year financial trends, key products and key competitors
  • Includes information on suppliers/ partners, shareholding structure and key employees with biographies

Highlights

NitroMed is engaged in the development and commercialization of pharmaceutical products for cardiovascular indications. The company has developed Nitric Oxide (NO) technology that provides stable and pharmaceutically elegant forms of NO to produce new NO-based compounds and extend the product lifecycle of existing medicines by adding an NO-donor.

The company's total revenues increased at a CAGR of 86% during 2002-2006, from $1 million to $12 million. The company's major contributor to revenue growth during 2002-2006 was BiDil whose sales increased at an absolute growth of +$12 million during the period.

NitroMed's sole contributor to sales growth out to 2010 will be the sales of BiDil. The drug is indicated for the treatment of heart failure in African-Americans. Revenues from BiDil are expected to increase at a CAGR of 63%, from $12 million in 2006 to $86 million in 2010. This represents an absolute growth of +$74 million for the same period.

Reasons to Purchase

  • Access all the important information and analysis on the company in a single report
  • Understand company's strengths, weaknesses, opportunities and threats along with business strategy and value chain
  • Gain access to company's adjusted five year financial data along with key ratios and market capitalization

Contents

  • Overview
  • Catalyst
  • Summary
  • Company Structure
    • Company Overview And Key Facts
    • Business Description
    • History
    • Company Financials
    • Stock Market Performance
    • P&L
    • Balance Sheet
    • Cash Flow
    • Business Segment Performance
    • Products & Services
    • Marketed Products
    • Pipeline Products
    • Historical Product Sales
    • Ac Forecast Product Sales
    • Competitors And Strategic Business Relationships
    • Key Competitors
    • Key Suppliers
    • Key Clients
    • Shareholding Structure
    • Strategy
    • Company View
    • Corporate Strategy
    • Swot Analysis
    • Overview
    • Strengths
    • Weaknesses
    • Opportunities
    • Threats
    • Value Chain Analysis
    • Overview
    • Product Development
    • Sales
    • Scorecard
    • Overview
    • Scorecard Analysis
    • Key Employees
    • List Of Key Employees
    • Key Employee Biographies
    • Financial And Operational Overview
    • Financial And Operational Overview
  • Appendix
  • Ask The Analyst
  • Datamonitor Consulting
  • Disclaimer
  • Table Of Figures
    • Figure 1: Nitromed - Operating Revenue/Cost Analysis, 2002-2006 ($ Mn)
    • Figure 2: Nitromed - Key Strategic Revenues, 2002-2006 ($ Mn)
  • Table Of Tables
    • Table 1: Nitromed - Key Facts
    • Table 2: Nitromed - Year-End Share Price And Market Capitalization, 2002-2006 ($)
    • Table 3: Nitromed - Key Events Impacting Share Price Performance
    • Table 4: Nitromed - Operating Revenue/Cost Analysis, 2002-2006 ($ Mn)
    • Table 5: Nitromed - Operating Cost Ratio Analysis, 2002-2006 (% Of Total Revenues)
    • Table 6: Nitromed - Balance Sheet, 2002-2006 ($ Mn)
    • Table 7: Nitromed - Cash Flow, 2002-2006 ($ Mn)
    • Table 8: Nitromed - Revenue Breakdown, 2002-2006 ($ Mn)
    • Table 9: Nitromed - Marketed Products
    • Table 10: Nitromed - In-House Pipeline Products
    • Table 11: Nitromed - Historical Product Sales, 2002-2006 ($ Mn)
    • Table 12: Nitromed - Forecast Sales, 2006-2010 ($ Mn)
    • Table 13: Nitromed - Key Competitors
    • Table 14: Nitromed - Key Suppliers
    • Table 15: Nitromed - Key Clients
    • Table 16: Nitromed - Key Shareholders
    • Table 17: Nitromed - Swot Analysis Summary
    • Table 18: Nitromed - Value Chain Analysis
    • Table 19: Nitromed - Scorecard
    • Table 20: Nitromed - Key Employees
    • Table 21: Nitromed - Financial And Operational Overview